Physician profile
James R Eells
NPI 1679546139
$286.08
in general payments reported to CMS, 2019-2025
8 companies · $41.42 in 2025
The $41.42 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.38 · 2021: $44.47 · 2022: $12.97 · 2023: $30.63 · 2024: $145 · 2025: $41.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $89.34 | 2023-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $70.99 | 2020-2024 | Breztri |
| Astellas Pharma US INC | $31.40 | 2024 | Veozah |
| Genentech USA, INC. | $27.17 | 2021-2022 | |
| Exact Sciences Corporation | $19.81 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $18.57 | 2024 | Repatha, Otezla |
| Indivior INC. | $17.50 | 2025 | Sublocade |
| Abbvie INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Eells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.